The global burn care market size was valued at USD 2.43 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.15% from 2023 to 2030. The demand for burn care products is on a rise owing to the rising incidence of burns, high demand for skin grafts, growing awareness regarding treatment options, and increasing technological advancements. Increasing awareness level among the people regarding various treatment options related to burn care is a key factor driving the market over the forecast period. The market is also gaining pace owing to the rising willingness among people to spend more and opt for new advanced burn care products.
The demand for burn care products used in home settings has increased eventually, to avoid visiting healthcare facilities, especially in the post-pandemic era. In addition, many patients adopted online counseling for their health-related concerns. Key players in the market are launching products to provide online counseling and guidance to patients who cannot visit healthcare facilities for treatment. For instance, Healogics, Inc. launched the Healogics Telehealth Program, telehealth for wound care patients, during the COVID-19 crisis. It provides patients access to continued wound care and various options of wound care treatments to help limit the potential need for hospitalization or emergency room admission. Some wound care centers are engaged in supporting hospitals with COVID-19 treatment. Therefore, this program allows patients at these centers to receive continuous wound care.
In addition, many doctors and clinicians are also using telehealth to treat their patients and provide knowledge regarding the use of advanced wound care products. The following are the latest insights published on MobiHealthNews (HIMSS) in December 2021: VeCare, a point-of-care wound evaluation platform developed by researchers from the National University of Singapore, consists of a smart bandage with sensors and a smartphone app for remote wound monitoring. This wearable device can detect factors of chronic wounds within 15 minutes. Such factors are further contributing to market growth.
Favorable government initiatives such as reimbursement policies which cover almost 70.00-100.00% of the treatment cost urge the patients to opt for advanced burn care treatment. The presence of government organizations such as the World Health Organization (WHO) and non-profit organizations like the American Burn Association (ABA) also contribute to increasing awareness levels. The WHO has been collaboratively working with The International Society for Burn Injuries and other such organizations to develop strategies to improve burn care and prevent burn injuries globally.
Skin grafts are majorly used on partial and full-thickness burns and have an important role in the treatment of burn injuries. Skin grafts can be biological or synthetic in nature. Owing to this trend, the demand for use of skin grafts and other skin substitutes in the treatment and management of acute burns has increased and is rising at a constant pace. In addition, key players operating in the market are focusing on planned initiatives like the launch of new products, and mergers and acquisitions are helping the market grow. For instance, in January 2023, Convatec Group PLC launched Convafoam, an advanced foam dressing in the U.S. The product is designed to fulfill the needs of patients and healthcare providers. It can be used for various types of wounds at any stage of the wound, which makes it the simple dressing choice for skin protection and wound management.
The advanced dressing segment dominated the market and accounted for the largest revenue share of 43.6% in 2022 owing to the wide product range and extensive application in wound management. Advanced wound dressings include collagen, alginate, hydrocolloid, hydrogel dressings, foam, and film dressings as well as other advanced dressing products. In addition, the development of advanced products such as ConvaTec’s FoamLite foam dressing, which can be used for a range of low to heavy exuding wounds, is further contributing to the growth of this segment.
The biologics segment is anticipated to witness the fastest growth over the forecast period owing to the introduction of new products and extensive R&D in this field. Biologics involve the application of active biological agents and molecules, such as monoterpenes (sulbogin, thymol, and sericin) that are antioxidants, antimicrobials, and anti-inflammatory in nature. Biologic dressings also include skin grafts (allografts, xenografts, autografts, or cadaveric human skin) and tissue-engineered products designed to replace the function and form of skin, either temporarily or permanently. The ready availability of skin from patients in case of biologic skin dressings or skin grafts is the major advantage for skin grafts.
The minor burn segment is expected to grow at significant pace with CAGR of 7.34% over the forecast period from 2023 to 2030. According to the National Center for Injury Prevention and Control, 1.2 million people in the U.S. are affected by burn injuries annually. Minor burns market is expected to exhibit steady growth rate over the forecast period. Treatment of minor burns includes traditional burn care products such as gauze, tapes, and bandages. Advanced dressings are seldom used for treating minor burns.
Chronic wounds include partial thickness and full thickness burns. These conditions take longer time for healing and cover more than 15.0% of the body. Partial thickness burn segment is anticipated to exhibit the fastest growth over the forecast period. According to U.S. FDA, approximately 40,000 people are hospitalized each year due to partial burns. The demand and usage of biologics such as skin grafts and advanced dressings for treatment of partial burns is increasing, thereby boosting the growth of this segment.
The thermal burns segment accounted for the largest revenue share of 74.9% in 2022 owing to a high incidence of fire-related burn injuries. According to the American Burn Association (ABA), fire burns are responsible for 43.0% of the total burn admissions to burn centers. Scalding is caused by hot liquids or gases and most commonly occurs from exposure to high temperature tap water in baths or showers, hot cooking oil, steam, and hot drinks. Children are particularly at risk of accidental burns.
The chemical burn segment is expected to witness the fastest growth over the forecast period. Chemical burns occur when the skin encounters chemicals or their fumes and corrosive products, most probably acids. Chemicals or fumes diffuse into the skin and damage the underlying tissue without causing any apparent damage to the surface. Chemical burns occur immediately on contact. Prolonged exposure severely damages human tissues and leads to scarring. Acids damage cells by coagulating them, while bases liquefy cells. Alkalis cause more injury than acids and bases as they react with the lipids within the body.
The hospitals segment accounted for the largest revenue share of 41.0% in 2022 owing to the increasing incidence of burn injuries and hospitalizations each year. According to NCBI, approximately 486,000 people are affected by burn injuries every year. According to the CDC, over 40,000 severely burned patients are hospitalized each year in the U.S. The rising incidence of burn injuries is expected to boost market growth. Furthermore, hospitals provide advanced burn care products, which contribute to the overall growth of the hospitals segment. Hospitals also provide a large array of treatment options pertaining to burn care. Hospitals follow 504 DRG to provide quick reimbursements for burn-affected patients from the Medicare program. These factors are responsible for the growth of the segment.
The others segment is expected to be the fastest-growing segment and is expected to witness a CAGR of around 8.0% over the forecast period. The others segment includes home care and ambulatory care. Ambulatory burn care encompasses a wide array of clinical services for outpatients. It serves as a critical factor when patients affected by burns are transported or relocated to hospitals. In case of partial or full-thickness burns, the patient needs to be provided with immediate and proper care. This is provided with the help of ambulatory services. Government initiatives undertaken for improving healthcare expenditure and infrastructure are also aiding in the growth of the segment.
North America dominated the burn care market and accounted for the largest revenue share of around 51.8% in 2022, owing to the increasing incidence of burns. According to a 2018 report by the American Burn Association, over 300 children are treated in emergency rooms in the United States each day, with roughly two children dying from burn injuries. In the U.S., children aged 16 and under account for roughly 26% of all burn center admissions. In addition, the National Center for Biotechnology Information (NCBI) estimates that 486,000 individuals are injured by fire each year. Thereby, burn care products are anticipated to be in high demand because of a high rate of burns.
Moreover, the presence of key market players in this region, focusing on strategic initiatives such as the launch of new products and mergers and acquisitions, is expected to create lucrative growth opportunities in the region. For instance, MiMedx Group Inc., in September 2020, introduced the EpiCord Expandable, a placental tissue allograft, to the market. This allograft's innovative design allows healthcare providers to cover up to twice the surface area and is intended to meet the needs of patients with larger, chronic, and difficult-to-heal wounds. As a result of the foregoing factors, the market in this region is expected to be one of the largest and grow in the future.
In Asia Pacific, the market is anticipated to witness the fastest CAGR of 8.6% over the forecast period. According to the WHO, the incidence of burn injuries that require immediate medical attention is approximately 20 times higher in the Western Pacific Region in comparison with the Americas. Moreover, each year, approximately 50,000 burns-related hospital admissions are recorded in Australia, with young children being particularly vulnerable. Scald burns (65%) and flame burns (20%) are the most common burn-related injuries among children aged four and under. Thus, an increase in the incidence of burn injuries is a major factor boosting the market in this region.
In addition, increasing R&D activities by key market players for the introduction of innovative products is expected to fuel market growth over the forecast period. For instance, researchers at the University of South Australia, are developing stimuli-responsive dressings that securely reduce infection and stimulate healing. The team has developed an advanced silver nanoparticle hydrogel-coated dressing that might revolutionize burns treatments in children. Thus, the aforementioned factors are projected to drive the market in this region.
Key players are adopting various strategies such as mergers and acquisitions, product launches, partnerships, and geographical expansions to strengthen their foothold in the market. For instance, in May 2020, Integra LifeSciences announced a positive clinical result for Integra Bilayer Wound Matrix (IBWM). This product is part of the company’s regenerative technology portfolio that uses collagen and amniotic products. Also, in June 2022, Smith & Nephew PLC announced the construction of a new manufacturing and R&D facility for its Advanced Wound Management in the outskirts of Hull, UK. Such initiatives are expected to help the market players tap the innovative solution market and provide surgeons with repair and wound closure solutions. Some prominent players in the burn care market include:
3M
Hollister Incorporated
Cardinal Health
Integra LifeSciences Corporation
Coloplast Corp.
DeRoyal Industries, Inc.
Smith & Nephew
ConvaTec Inc.
Mölnlycke Health Care AB.
Johnson & Johnson
Report Attribute |
Details |
Market size value in 2023 |
USD 2.6 billion |
Revenue forecast in 2030 |
USD 4.22 billion |
Growth Rate |
CAGR of 7.15% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Report updated |
May 2023 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, depth of burn, cause, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Norway; Sweden; India; Singapore; South Korea; China; Japan; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
3M, Hollister Incorporated, Cardinal Health, Integra LifeSciences Corporation, Coloplast Corp., DeRoyal Industries, Inc., Smith & Nephew, ConvaTec Inc., Mölnlycke Health Care AB and Johnson & Johnson |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global burn care market on the basis of product, depth of burn, cause, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Advanced dressing
Alginate Dressing
Collagen Dressing
Hydrogel Dressing
Hydrocolloid Dressings
Wound Contact Layers
Film Dressings
Foam Dressings
Others
Biologics
Traditional Burn Care Products
Others
Depth of Wound Outlook (Revenue, USD Million, 2018 - 2030)
Minor Burns
Partial Thickness Burns
Full Thickness Burns
Cause Outlook (Revenue, USD Million, 2018 - 2030)
Thermal Burns
Electrical Burns
Radiation Burns
Chemical Burns
Friction Burns
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
b. The global burn care market size was estimated at USD 2.4 billion in 2022 and is expected to reach USD 2.6 billion in 2023.
b. The global burn care market is expected to grow at a compound annual growth rate of 7.15% from 2023 to 2030 to reach USD 4.2 billion by 2030.
b. Thermal burns held the largest share of the burn care market in 2022 with a market share of more than 74.9% owing to a rising incidence of fire-related burn injuries.
b. Some key players operating in the burn care market include Smith & Nephew, Johnson & Johnson, ConvaTec Inc., Mölnlycke Health Care AB, and 3M.
b. Key factors that are driving the burn care market growth include rising demand for minimally invasive procedures to improve cosmetic appeal for patients suffering from burns.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.